Cerebral hemodynamics during controlled hypotension induced by the continuous infusion of ganglionic blocking agents (hexamethonium, pendiomide and arfonad). 1954

J H MOYER, and G MORRIS

UI MeSH Term Description Entries
D007022 Hypotension Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients. Blood Pressure, Low,Hypotension, Vascular,Low Blood Pressure,Vascular Hypotension
D007023 Hypotension, Controlled Procedure in which arterial blood pressure is intentionally reduced in order to control blood loss during surgery. This procedure is performed either pharmacologically or by pre-surgical removal of blood. Controlled Hypotension,Hypotension, Induced,Induced Hypotension
D009125 Muscle Relaxants, Central A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) Centrally Acting Muscle Relaxants,Central Muscle Relaxants,Relaxants, Central Muscle
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005730 Ganglionic Blockers Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery. Ganglionic Blocking Agents,Ganglioplegic Agents,Blocking Agents, Ganglionic,Ganglionic Blockaders,Agents, Ganglionic Blocking,Agents, Ganglioplegic,Blockaders, Ganglionic,Blockers, Ganglionic
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D001337 Autonomic Agents Agents affecting the function of, or mimicking the actions of, the autonomic nervous system and thereby having an effect on such processes as respiration, circulation, digestion, body temperature regulation, certain endocrine gland secretions, etc. Autonomic Drugs,Autonomic Effect,Autonomic Effects,Agents, Autonomic,Drugs, Autonomic,Effect, Autonomic,Effects, Autonomic
D013565 Sympatholytics Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. Sympathetic-Blocking Agents,Sympatholytic,Sympatholytic Agent,Sympatholytic Drug,Sympatholytic Agents,Sympatholytic Drugs,Sympatholytic Effect,Sympatholytic Effects,Agent, Sympatholytic,Agents, Sympathetic-Blocking,Agents, Sympatholytic,Drug, Sympatholytic,Drugs, Sympatholytic,Effect, Sympatholytic,Effects, Sympatholytic,Sympathetic Blocking Agents
D014294 Trimethaphan A nicotinic antagonist that has been used as a ganglionic blocker in hypertension, as an adjunct to anesthesia, and to induce hypotension during surgery. Thimethaphan,Trimetaphan
D018738 Hexamethonium A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool. Depressin,Hexamethonium Bitartrate,Hexamethonium Bromide,Hexamethonium Chloride,Hexamethonium Dibromide,Hexamethonium Dibromide Dihydrate,Hexamethonium Dichloride Dihydrate,Hexamethonium Dihydroxide,Hexamethonium Diiodide,Hexamethonium Dimethylsulfate,Hexamethonium Diperchlorate,Hexamethonium Iodide,Hexamethonium Monotartrate,Hexonium,Bitartrate, Hexamethonium,Bromide, Hexamethonium,Chloride, Hexamethonium,Dibromide Dihydrate, Hexamethonium,Dibromide, Hexamethonium,Dichloride Dihydrate, Hexamethonium,Dihydrate, Hexamethonium Dibromide,Dihydrate, Hexamethonium Dichloride,Dihydroxide, Hexamethonium,Diiodide, Hexamethonium,Dimethylsulfate, Hexamethonium,Diperchlorate, Hexamethonium,Iodide, Hexamethonium,Monotartrate, Hexamethonium

Related Publications

J H MOYER, and G MORRIS
November 1978, Nihon rinsho. Japanese journal of clinical medicine,
J H MOYER, and G MORRIS
April 1955, The Journal of pharmacology and experimental therapeutics,
J H MOYER, and G MORRIS
January 1956, Anesthesie et analgesie,
J H MOYER, and G MORRIS
September 1954, The Journal of clinical investigation,
J H MOYER, and G MORRIS
October 1954, Nordisk medicin,
J H MOYER, and G MORRIS
October 1955, Giornale italiano di chirurgia,
J H MOYER, and G MORRIS
November 1971, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Copied contents to your clipboard!